论文部分内容阅读
目的为了探讨Ⅲ型前列腺炎合并ED患者的临床治疗有效方法,特进行了本临床观察;方法选择符合诊断患者120例,随机分为治疗组和对照组,对照组给予常规治疗方法,治疗组加用左归丸治疗,观察其临床疗效;结果治疗两个疗程后进行NIH-CPSI与治疗前比较,均取得了较高的疗效,两组比较无显著性差异(P>0.05),IIEF-5评分,应用左归丸的治疗组明显优于对照组(P<0.05);结论左归丸应用于治疗Ⅲ型前列腺炎合并ED的患者,具有确切的疗效。
Objective To investigate the clinical treatment of type Ⅲ prostatitis patients with ED effective methods, especially the clinical observation; Methods 120 patients were selected in line with the diagnosis, were randomly divided into treatment group and control group, the control group given conventional treatment, the treatment group plus With Zuogui pill treatment to observe its clinical efficacy; Results After treatment for two courses of NIH-CPSI compared with before treatment, have achieved higher efficacy, no significant difference between the two groups (P> 0.05), IIEF-5 Score, Zuogui pill treatment group was significantly better than the control group (P <0.05); Conclusion Zuogui pill used in the treatment of type Ⅲ prostatitis patients with ED, with the exact effect.